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Long-term results of stent graft treatment of
subclavian artery injuries: Management of choice
for stable patients?
Daniel F. du Toit, MD, Anton V. Lambrechts, MD, Hugo Stark, MD, and
Brian L. Warren, MD, Tygerberg, South Africa
Background: The management of penetrating subclavian artery injuries poses a formidable surgical challenge. The
feasibility of stent graft repair is already established. General use of this modality is not widely accepted due to concerns
regarding the long-term outcome in a generally young patient population. We review our stent graft experience to
examine long-term outcomes.
Methods: All patients with penetrating subclavian artery injuries were evaluated for stent graft repair. Patients were
excluded when hemodynamically unstable or unsuitable on other clinical and angiographic grounds. Patients were
followed prospectively for early (<30 days) and late (>30 days) complications. Clinical and telephone evaluation,
Doppler pressures, duplex Doppler, and angiography (when indicated), were used to asses patients at follow-up.
Outcomes were recorded as technical success of procedure, graft patency, arm claudication, limb loss, the need for open
surgical repair, the presence or absence of other complications, and death.
Results: Fifty-seven patients underwent stent graft treatment during the 10-year period. Mean age was 34, and 91% were
men. There were 53 stab wounds and four gunshot injuries. Pathology included false aneurysms (n  42), arteriovenous
fistula (n  12), and three arterial occlusions. Early complications: One patient (2%) had a femoral puncture site injury
which was managed with open surgical repair. One patient died early due to multiple organ failure related to concomitant
injuries. Three patients (5%) presented with graft occlusion and nonlimb threatening ischemia in the first week after
treatment. All three patients were managed successfully with a second endovascular intervention. Late complications:
Twenty-five (44%) of the 57 patients with subclavian artery injuries were followed-up with a mean duration of 48 months.
Two patients died as a result of fatal stab wounds months after their first injuries. Five patients (20%) and three patients
(12%) presented with angiographically significant stenosis and occlusions, respectively. The stenotic lesions were
successfully managed with endovascular intervention, and the occluded lesions were managed conservatively. No patient
experienced life or limb loss or any incapacitating symptoms at the end of the study period. There was no need for
conversion to open surgery.
Conclusions: This study has reaffirmed the feasibility and safety of stent graft repair in treating stable patients with selected
penetrating subclavian artery injuries. The results of this study also confirmed acceptable long-term follow-up without
any limb or life threatening complications. We conclude that endovascular repair should be considered the first choice of
treatment in stable patients with subclavian artery injuries. ( J Vasc Surg 2008;47:739-43.)The management of subclavian artery injuries presents
a considerable challenge to even the most experienced
vascular surgeon.1 The collective experience in treating
these lesions remains limited in most vascular units. Com-
plex surgical exposures required for conventional open
repair contribute to a high morbidity and mortality.2,3
Endovascular repair offers an attractive alternative to open
surgery for the management of these injuries and the safety
and efficacy thereof has been previously reported.4-6 Con-
cerns regarding the long-term outcome in young trauma
patients prevents general acceptance. This report describes
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METHODS
All patients with subclavian artery injuries presenting
between November 1997 and July 2007 who qualified for
endovascular repair were included in this study. Patient
selection was based on clinical presentation and diagnostic
angiography. Clinical contraindications to stent grafting
included active uncontrollable hemorrhage, critical limb
ischemia, airway or brachial plexus compression, concomi-
tant aero-digestive injuries, and infected wounds. Arterio-
graphic contraindications were excessive luminal discrep-
ancy between the proximal and distal involved artery and an
inability to traverse the lesion by guidewire.
The procedures were performed in an arteriography
suite equipped for general anesthesia and conventional
surgery. Intravenous heparin (50 units/kg) and prophylac-
tic cefazolin were routinely administered before stent graft
deployment and empirically continued for 24 hours at a
dosage of 5000 units subcutaneously and 1 gram intrave-
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access was gained under local anesthesia. Anatomical loca-
tion of lesions and proximal and distal vessel diameter were
determined with routine angiography, and a final decision
regarding stent graft treatment was then taken. As part of
this procedure, the inability to pass a guidewire and a lumen
discrepancy between the proximal and distal involved arter-
ies that would not allow proximal oversizing of 1 mm
without damaging a much smaller distal artery, would
exclude stent graft placement.
Details of the procedure have been previously de-
scribed.5,6 All stent grafts were placed via a percutaneous
transfemoral approach. Bilateral transfemoral access (5F
and 9F Cordis [Johnson & Johnson, Waterloo, Belgium]
introducer sheaths) were obtained. The appropriate stent
graft was introduced via the 9F sheath (11 cm in length)
over a stiff guidewire, crossing the lesion, and angiographic
control for precise deployment was provided by a diagnos-
tic catheter (via the 11 cm 5F sheath) positioned in the
proximal subclavian artery or aortic arch. Early in the study,
long introducer sheaths (100 cm in length) were not avail-
able locally, and therefore, it was used in very few of these
cases. It has the advantage of only one femoral puncture
providing stent graft access and angiographic control of
deployment, but in very proximal injuries achieving a stable
position may be difficult. The stent grafts used included
nine Hemobahn endovascular prosthesis (W. L. Gore), 20
Wallgraft (Boston Scientific, Target Therapeutics, Fre-
mont, Calif), 27 Fluency (Bard, Murray Hill, NJ), and one
custom-made stent graft consisting of a Palmaz stent with
polytetrafluoroethylene (ePTFE) sutured on to it. No long-
term anticoagulation or antiplatelet drugs were prescribed.
Data on each patient was collected prospectively from
the time of admission. Planned postoperative evaluation
included clinical and duplex Doppler evaluation after 1
month and thereafter 3 to 6 monthly, up to the end of the
study. Evaluation criteria were graft patency, arm claudica-
tion, limb loss, the need for open surgical repair, the
presence or absence of other complications, and death.
Concerted attempts were made to trace patients not at-
tending follow-up appointments. When telephone contact
was made, the presence or absence of claudication in the
relevant upper limb was established. Diagnostic and thera-
peutic angiography was performed if symptomatic stent
graft stenosis or occlusion were suspected.
RESULTS
Initial treatment. During the 10-year study period,
Table I. Subclavian arterial pathology
Lesion Number
False aneurysm 42
Arteriovenous fistula 12
Occlusion 3
Total 57145 patients with subclavian artery injuries were seen andmanaged. Fifty-seven patients (52 male; 5 female) with a
mean age of 34 years (range 18-69) underwent stent graft
treatment and the remaining 88 open surgery. Fifty-three
injuries were the result of stab wounds and four were gunshot
injuries. The arterial pathology is depicted in Table I. The
most common injuries encountered were false aneurysms
(n  42), followed by arteriovenous fistula (n  12).
Forty-five patients were treated within 1 week of the time of
injury, 11 patients within 1 month, and one patient more
than 2 years after the injury. The 88 patients that under-
went open surgery were excluded form stent graft treat-
ment for clinical contraindications (n  70), the unavail-
ability of endovascular service after-hours (14), and
radiological contraindications (4).
A variety of stent graft diameters (7-10 mm) and
lengths (30-60 mm) were used. Two patients required
second stent grafts to repair type 1 endoleaks caused by
incorrect positioning of the first stent grafts. All patients in
whom endovascular management was attempted by de-
ployment of a stent graft were successfully treated initially.
Success was defined as complete exclusion of the lesion with
no endoleaks, as confirmed by completion angiography. In
none of the patients in whom a stent graft was deployed was
it necessary to convert to open repair, and no periproce-
dural blood transfusions were required.
Early complications (<30 days) (Table II). One
patient presented with lower limb ischemia as a result of a
femoral puncture site intimal flap, requiring surgical repair.
A second patient died 10 days after stent graft placement.
The cause of death was multiple organ failure (this patient
had multiple other injuries related to her assault). Three
patients (5%) presented within the first week after treat-
ment with early stent graft occlusions, associated clinically
with nonlimb-threatening ischemia. One patient presented
Table II. Early and late complications
Early (30 days)
Femoral artery puncture site intimal flap requiring surgical
repair: 1
Early stent thromboses: 3
Death due to multiorgan failure: 1
Late (30 days)
50% stent graft stenosis: 5 (mean 11 months; range 2-25
months)
Stent graft occlusion: 3 (mean 26 months; age 23-32 months)
Stabbed to death with stent grafts patent: 2 (13 and 30
months)
Table III. Follow-up
Patients Number
Total 57
Early death 1
Lost to follow-up 31
Follow-up – alive 23
Follow-up – late death 2with proximal stent graft collapse and thrombosis. This
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and it is postulated that the hematoma accentuated the
compression of the stent graft between the first rib and the
clavicle. He was successfully treated with catheter directed
thrombolysis using streptokinase and a second stent graft to
open the proximal collapsed segment of the first stent graft.
This patient was still followed-up at the end of the study
period (telephonical contact at 89 months) without any
problems. A second patient presented with a thrombosed
stent graft for no apparent reason. This was corrected with
catheter directed thrombolysis and the stent graft remained
patent at 36-month Duplex Doppler follow-up and asymp-
tomatic at 88-month clinical follow-up. The third throm-
bosed stent graft was also treated with catheter directed
thrombolysis and revealed a distal stenosis that was success-
fully treated in the short term with balloon angioplasty.
This patient was then lost to follow-up.
Long-term follow-up and complications (Table III).
Patient availability for long-term follow-up is depicted in
Table III. Thirty-one of the surviving 56 patients with subcla-
vian stent grafts were completely lost to follow-up after their
initial management. The mean duration of the follow-up of
the remaining 25 patients was 49 months (range 5-104
Table IV. Follow-up data for 25 patients
Patient
no Last follow-up: Status (Months)
1 Telephonic: Asymptomatic (72)
4 Duplex Doppler: Normal (12)
5 Telephonic: Asymptomatic (104) D
6 Duplex Doppler: Normal (12)
8 Telephonic: Asymptomatic (102) D
10 Doppler pressures: Normal (97)
11 Duplex Doppler: Normal (54)
14 Duplex pressures: Normal
Clinical: Asymptomatic
(88) D
A
15 Telephonic: Asymptomatic (89) A
17 Clinical: Asymptomatic (29) A
18 Clinical: Nonincapacitating claudication
Arteriogram: Stent graft occluded
(32)
19 Doppler pressures: Normal (86)
24 Telephonic: Asymptomatic (77) A
25 Clinical: Asymptomatic (76) A
29 Doppler pressures: Normal (71) D
A
33 Arteriogram: Occluded stent graft (23)
35 Arteriogram: Stent graft stenosis/PTA (5)
36 Clinical: Asymptomatic (12)
37 Telephonic: Asymptomatic (55)
38 Telephonic: Asymptomatic (51) D
A
40 Telephonic: Asymptomatic (26)
45 Telephonic: Asymptomatic (22)
51 Telephonic: Asymptomatic (13)
52 Telephonic: Asymptomatic (12)
55 Doppler pressures: Normal (11)
PTA, Percutaneous transluminal angioplasty.
aDeath by subsequent violent assault.months). Nine of these patients had incomplete follow-up,being lost before the end of the study period but 16 could
still be contacted either telephonically or personally. The
complete follow-up data of these 25 patients are recorded
in Table IV.
Among the nine patients that were lost before the end
of the study, two late deaths, the result of subsequent
violent assaults, were recorded. Both patients were asymp-
tomatic and clinically seen with equal radial pulses and
Doppler pressure measurements shortly before their deaths.
Of all patients available for evaluation, five patients (20%)
presented with angiographically significant (50%) stenosis
(at mean follow-up of 11 months; range 2-25 months) and
three (12%) with stent graft occlusion (at mean follow-up of
26 months). The five stent grafts with stenoses were all
proximal and in-stent stenoses, and one had significant
poststent dilatation that remodeled on follow-up after bal-
loon angioplasty. In total, significant stenosis or occlusion
took place in eight (32%) of the 25 patients available for
long-term follow-up. These eight patients all presented
with non-incapacitating claudication, and the stenotic le-
sions were all successfully treated with angioplasty and
remained patent on follow-up. Occlusions were treated
conservatively, without a requirement for open surgery to
rior follow-up information (months)
Still in follow-up at
end of study period
— No
— No
Doppler: Normal (3) Yes
— Noa
Doppler: Normal (1) Yes
— Yes
— No
Doppler: Normal
gram: Occluded stent graft/
mbolysis
(36)
(1)
Yes
gram: Occluded stent graft/
mbosis
(1) Yes
gram: Stent graft stenosis/PTA (15) Noa
— No
— Yes
gram: Stent graft stenosis/PTA (25) Yes
gram: Occluded stent graft (24) Yes
Doppler: Normal
gram: Stenosis/PTA
(19)
(2)
Yes
— No
— No
— No
— Yes
Doppler: Normal
gram: Stent graft stenosis/PTA
(12)
(7)
Yes
— Yes
— Yes
— Yes
— Yes
— YesP
uplex
uplex
uplex
rterio
thro
rterio
thro
rterio
rterio
rterio
uplex
rterio
uplex
rterioimprove symptoms or to achieve limb salvage. No patient
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stent grafts presenting with occlusion all presented late and
no attempt at chemical or mechanical thrombolysis were
made. Structurally, these seven stent grafts were intact, and
no evidence of stent graft fracture or compression between
the first rib and clavicle were present. None of the patients
presented with early or late graft sepsis.
In total, stent graft failures amounted to six occlusions
(three early; three late) and five significant (50%) stenoses
(two within 6 months and the remainder late). None of
these stent grafts were Hemobahn (nitinol) stents, 10 were
Wallgraft (stainless steel) stents, and one was a Fluency
(nitinol). The failure rate for the Hemobahn stents was
none of nine, for Wallgraft stents 10 of 20 (50%), and for
the Fluency stents, one of 27 (4%). The patient with the
custom-made stent graft remained asymptomatic for the
duration of the study.
DISCUSSION
The treatment of subclavian artery injuries can pose a
major challenge even in the elective setting where access
may requires a sternotomy or thoracotomy.7-9 Overall
mortality, including deaths at the scene, is reported to be as
high as 70% to 80% and, in patients surviving to the
operating room, 5% to 15%.9 We and others previously
reported the endovascular management of these injuries in
selected patients to be a safe, effective, and minimally
invasive alternative to open repair.6,10 This was again con-
firmed in this large study with a technical success rate of
100% and no procedure-related deaths or limb loss occur-
ring. Early stent graft failure (within 30 days) occurred in
three of 57 subclavian artery injuries (5%). Review of the
literature on open repair of subclavian artery injuries, re-
veals early failure rates reported by McKinley et al11 (12 of
236 repairs) and Degiannis et al12 (3 of 54 repairs) to be
about 5%. As a whole, the early graft failure rate of endo-
vascular repair of this vessel compares favorably with open
repair. None of these patients presented with critical arm
ischemia or other thromboembolic complications. Two
of them were, after the initial correction of patency,
followed-up for more than 7 years with no upper limb
complaints. All three stent graft thromboses occurred early
in our experience and with Wallgrafts. Factors that could
have played a role include choosing a too short stent graft,
not covering all residual clots in the vicinity of the injury,
and compression of the less flexible stents, especially when
used in patients with large false aneurysms, causing com-
pression of the device in relation to the clavicle and first rib.
In this study, no short or long-term antiplatelet therapy was
attempted due to poor patient compliance. It might be of
some benefit in terms of stent graft patency in individual
patients in a more reliable patient population.
As a result of the notorious difficulty in follow-up of
trauma patients, long-term outcome statistics are difficult
to collect. The same is true for open surgery and medium-/
long-term data following the performance of open surgery
in this group of patients is lacking. This series presents a
single center experience with the endovascular treatment ofa selected group of patients with an intensive effort to
maintain follow-up during a 10-year period. We initially
planned to asses all patients on follow-up by clinical examina-
tion (comparing radial pulses), Doppler pressure comparison,
duplex Doppler scanning, and angiography where necessary.
Duplex Doppler study can be inaccurate in the assessment of
subclavian stent graft patency due to the difficulty in visu-
alizing the artery posterior to the clavicle and sternum. As
the study progressed, it became increasingly difficult to
have patients attend follow-up visits, especially those with-
out symptoms or complications. We therefore relied more
on clinical evaluation, Doppler pressures, and telephonical
interview to detect pulses, incapacitating symptoms, limb
or life loss, or the need for open surgery elsewhere. Al-
though objective assessment of stent graft patency cannot
be claimed, due to erratic patient attendance for follow-up,
the success of treatment in terms of limb salvage, absence of
incapacitating symptoms, and survival has been determined
with reasonable accuracy.
Although the number of patients successfully followed-up
was only 26, the mean follow-up was fairly long at about 4
years. The 16 patients that were still followed-up at the end
of the study had a mean follow-up of 61 months (range
8-104). All these patients were alive, actively using their
arms without significant claudication, and with no other
stent graft related problems. The five patients (19%) who
complained of claudication all had significant stenoses on
arteriogram. We treated them all aggressively and success-
fully with balloon angioplasty. Inmost of these patients, the
claudication was mild and could probably have been ini-
tially managed conservatively. Three patients (12%) with
occlusions were all asymptomatic or experienced noninca-
pacitating symptoms that did not need further treatment.
Review of the literature fails to identify any long-term
follow-up results for open surgical repair of subclavian
artery injuries. This can be ascribed to the unreliable nature
of trauma patients and their generally poor socioeconomic
status.
Elective surgery for nontraumatic pathology of these
vessels does not represent a comparative model as the data
is limited and patient profile and differences in pathology
are confounding factors. It cannot be stated precisely how
many of the stent grafts are patent, but it can be said that, of
the 26 patients who were followed-up, none experienced
any limb or life threatening complications. This was also
true for the 16 patients that were still followed-up at the
end of the study (mean follow-up 61months) and, of these,
six patients had a patent graft on clinical examination (mean
follow-up 72 months).
A superiority of the more flexible Hemobahn and Flu-
ency stent grafts in comparison with the more rigid Wall-
graft in the tortuous subclavian artery in terms of patency,
stent deformation and stent compression has been reported
by others,13-15 and was also demonstrated in this series. All
three stents are self expandable with the Hemobahn and
Fluency consisting of a nitinol stent covered with ePTFE
and the Wallgraft being a super metal alloy-composed
(Elgiloy) stent, covered with woven low-porosity polyeth-
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ePTFE stents were 3%, and 50% for the Wallgraft. It is
unclear whether the stent metal, covering material, or both
contributed to the difference in outcome. No instance of
stent graft fracture in either group was encountered on
follow-up; a complication that has been described by other
authors for bare stents and covered stents in the subclavian
artery. This, however, only holds true for patients present-
ing with complications and a few others undergoing radio-
logical imaging at some stage. No significant endoleaks
translating to growing false aneurysms or other complica-
tions were encountered.
It is concluded that stent graft management of selected
subclavian artery injuries is safe with morbidity and mortal-
ity rates comparable with open surgery. The long-term
results demonstrated in this study are acceptable, and there
are no published results available to provide any evidence
that open surgerymight be better. In this unit, we therefore
would consider any patient stable enough to undergo an
angiogram as a possible candidate for stent graft treatment
if a subclavian artery injury is demonstrated. Emerging
clinical contraindications to endovascular management in-
clude a large hematoma causing compression symptoms,
concomitant injuries that warrant exploration in their own
right, such as tracheal or esophageal injuries, and grossly
infected wounds that might lead to graft sepsis. Technical
restrictions include a significant lumenal size discrepancy
between the proximal and distal parts of the involved
artery, leading to graft sizing difficulties, with the possibil-
ity of proximal endoleaks, or distal over sizing and vessel
damage. This is especially problematic when treating
chronic arteriovenous fistulae and can be partly overcome
by using tapered stents. Other technical restrictions include
an inability to traverse the lesion with a guide wire. This is
a potential problem with old arteriovenous fistulae, false
aneurysms, and arterial occlusions with widely displaced
proximal and distal arterial lumens. Femoral and brachial
punctures with snaring of the femoral guide wire in the
lesion via the brachial approach may potentially address this
problem. In this experience, 39% of all patients with sub-
clavian artery injuries qualified for stent graft treatment. We
believe that, with improving endovascular techniques and
increasing general acceptance of this modality, up to 50% of
injuries can be treated endovascularly. This correlates well
with a retrospective evaluation by Xenos,16 demonstrating
a 52% suitability of their patients for endovascular repair.
Stent graft repair is now our first choice in the management
of selected, stable patients with subclavian artery injuries.AUTHOR CONTRIBUTIONS
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